1. Home
  2. MDWD vs TWIN Comparison

MDWD vs TWIN Comparison

Compare MDWD & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • TWIN
  • Stock Information
  • Founded
  • MDWD 2000
  • TWIN 1918
  • Country
  • MDWD Israel
  • TWIN United States
  • Employees
  • MDWD N/A
  • TWIN N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • TWIN Industrial Machinery/Components
  • Sector
  • MDWD Health Care
  • TWIN Industrials
  • Exchange
  • MDWD Nasdaq
  • TWIN Nasdaq
  • Market Cap
  • MDWD 184.8M
  • TWIN 152.3M
  • IPO Year
  • MDWD 2014
  • TWIN N/A
  • Fundamental
  • Price
  • MDWD $19.02
  • TWIN $11.08
  • Analyst Decision
  • MDWD Strong Buy
  • TWIN
  • Analyst Count
  • MDWD 1
  • TWIN 0
  • Target Price
  • MDWD $25.00
  • TWIN N/A
  • AVG Volume (30 Days)
  • MDWD 61.7K
  • TWIN 25.7K
  • Earning Date
  • MDWD 11-26-2024
  • TWIN 02-05-2025
  • Dividend Yield
  • MDWD N/A
  • TWIN 1.47%
  • EPS Growth
  • MDWD N/A
  • TWIN N/A
  • EPS
  • MDWD N/A
  • TWIN 0.68
  • Revenue
  • MDWD $19,720,000.00
  • TWIN $304,470,000.00
  • Revenue This Year
  • MDWD $10.37
  • TWIN N/A
  • Revenue Next Year
  • MDWD $26.36
  • TWIN N/A
  • P/E Ratio
  • MDWD N/A
  • TWIN $16.24
  • Revenue Growth
  • MDWD N/A
  • TWIN 6.98
  • 52 Week Low
  • MDWD $11.04
  • TWIN $10.22
  • 52 Week High
  • MDWD $24.00
  • TWIN $18.00
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 61.79
  • TWIN 42.13
  • Support Level
  • MDWD $15.80
  • TWIN $10.22
  • Resistance Level
  • MDWD $18.25
  • TWIN $11.86
  • Average True Range (ATR)
  • MDWD 0.88
  • TWIN 0.49
  • MACD
  • MDWD 0.07
  • TWIN -0.06
  • Stochastic Oscillator
  • MDWD 95.27
  • TWIN 46.49

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: